Cost-effectiveness analysis of protease inhibitor monotherapy vs. ongoing triple-therapy in the long-term management of HIV patients

INTRODUCTION: Protease inhibitors might be sufficient to maintain complete virological suppression when used as monotherapy for HIV-1-positive patients who have achieved sustained virological suppression on combination antiretroviral therapy (ART). The present study estimated the cost-effectiveness...

Descripción completa

Detalles Bibliográficos
Autores principales: Oddershede, Lars, Walker, Simon, Paton, Nicholas, Stöhr, Wolfgang, Dunn, David, Sculpher, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2014
Materias:
Oral Presentation – Abstract O217
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224943/
https://www.ncbi.nlm.nih.gov/pubmed/25394007
http://dx.doi.org/10.7448/IAS.17.4.19498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224943/
https://www.ncbi.nlm.nih.gov/pubmed/25394007
http://dx.doi.org/10.7448/IAS.17.4.19498

Ejemplares similares